feed,title,long_url,short_url
SeekingAlpha,Bed Bath & Beyond stock slumps despite $120M merchandise agreement,https://seekingalpha.com/news/3954730,
SeekingAlpha,MorphoSys adds 16% on faster timeline for Phase 3 myelofibrosis program,https://seekingalpha.com/news/3954729,
SeekingAlpha,AbbVie downgraded to hold at Argus on Humira competition in US,https://seekingalpha.com/news/3954728,
